3[1]Kamel HK, Rodriguez-Saldana J, Flaherty JH, et al. Dia-betes melitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med, 1999, 15(2):265-267
4[2]UK Prospective Diabetes Study Group. Risk factorsfor coronary artery disease in non-insulin dependent diabetes mellitus. BMJ, 1998, 316:823-826
5[4]Becks PJ, Mackaay AJC, DeNeeling JNO, et al. Peripheralarterial disease in relation to glycemic level in an elderly caucasian population: The Hoorn Study. Diabetologia, 1995, 38:86-89
6[5]UK Prospective diabetes study group. Plasma lipids andlipoproteins at diagnosis of NIDDM by age and sex: UKPDS 27. Diabetes care, 1997, 20:1683-1689
7[8]Brown WV. Lipoprotein disorders in diabetes mellitus.Medical Clinics of North America, 1994, 78(1):143
8[9]Koskinen P, Manttari M, Manninen V, et al. Coronaryheart disease incidence in NIDDM patients in Helsinki heart study. Diabetes Care, 1992, 15(7):820-822
9[10]Bell DS. A comparison of lovastatin, an HMG-CoA reduc-tase inhibitor, with gemibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Clin-Ther, 1995, 17(5):901-905
10[11]Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascularevents and their reduction with pravastation in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events(CARE) trial. Circulation, 1998, 98:2513-2517
